Search Results 571-580 of 17009 for monoclonal antibody
... antibody can't bind to it or binds less tightly. ... Badley, could reduce or nullify beneficial effects of therapies that rely heavily on antibodies: monoclonal ...
... antibody therapy, such as trastuzumab emtansine (T-DM1) and/or pertuzumab ... Monoclonal antibodies, such as pembrolizumab, may block tumor growth in ...
... monoclonal anti-CD20 antibody, for patients with relapsed or refractory B Cell non-Hodgkin lymphoma (NHL). Participation eligibility. Participant eligibility ...
“Historically, patients with Crohn's disease have been treated sequentially with steroids, then azathioprine, then monoclonal antibodies such as infliximab.
... monoclonal antibody reversed the therapeutic effect of IVIG. Protection was associated with the ability of IVIG administration to induce surface expression ...
The primary purpose of this study is to evaluate the risk of progression from Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myleoma (MM) ...
... monoclonal gammopathy of undetermined significance and implications for recategorizing disease entities, which will be published in the October 2010 issue ...
... monoclonal antibody treatments than any other health care organization, demonstrating a significant decrease in hospitalization rates and mortality.
About this study. The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor ...
Immunotherapy with monoclonal antibodies such as ipilimumab and nivolumab may help the body's immune system attack the cancer and may interfere with the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.